Dr James N Glenn, MD in Emporia, KS - Orthopaedic Surgery

Dr James N Glenn, MD is a Orthopaedic Surgery physician based in Emporia, Kansas. Dr James N Glenn is licensed to practice in Kansas (license number 04-14326) and his current practice location is 1301 W 12th Ave, Ste 105, Emporia, Kansas. He can be reached at his office (for appointments etc.) via phone at (620) 343-1191.

NPI number for Dr James N Glenn is 1699778092 and his current mailing address is 1130 Oxford Drive, Emporia, Kansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1699778092.

Contact Information

	Dr James N Glenn, MD
	1301 W 12th Ave, Ste 105, Emporia, KS 66801-2588
	(620) 343-1191
	(620) 343-3139

Physician's Profile

Full Name	Dr James N Glenn
Gender	Male
Speciality	Orthopaedic Surgery
Location	1301 W 12th Ave, Emporia, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1699778092
Provider Enumeration Date: 05/31/2005
Last Update Date: 04/27/2012

Medical Identifiers

Medical identifiers for Dr James N Glenn such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1699778092	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207X00000X	Orthopaedic Surgery	04-14326 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr James N Glenn is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr James N Glenn, MD 1130 Oxford Drive, Emporia, KS 66801 Ph: (620) 343-1508	Dr James N Glenn, MD 1301 W 12th Ave, Ste 105, Emporia, KS 66801-2588 Ph: (620) 343-1191

News Archive

UC Riverside researchers create stable "abnormal N-heterocyclic carbenes"

Researchers at the University of California, Riverside have successfully created in the laboratory a class of carbenes, highly reactive molecules, used to make catalysts - substances that facilitate chemical reactions. Until now, chemists believed these carbenes, called "abnormal N-heterocyclic carbenes" or aNHCs, were impossible to make.

The Cambridge-MIT Institute has launched a project to tackle the bottlenecks that slow development of new drugs

The Next-Generation Drug Discovery Community will unite researchers at Cambridge University and MIT with partners from the information technology, pharmaceutical and biotechnology industries to find ways to speed up development of the next generation of drugs-particularly those that treat diseases with complex causes such as cancers, arthritis, multiple sclerosis and diabetes.

Graduate students develop novel microfluidic platform for monitoring single cell-level electroporation

Graduate students Mingde 'Jack' Zheng and Joseph Sherba have developed a novel, microfluidic platform for monitoring electroporation and molecular delivery at the single cell-level as part of a collaborative re-search team led by Professors Jeffrey Zahn and David Shreiber in the Department of Biomedical Engineer-ing and Professors Hao Lin and Jerry Shan in the Department of Mechanical and Aerospace Engineering at Rutgers,

Rhinosinusitis may be a factor in toxic shock syndrome in children

Rhinosinusitis (infection and inflammation in the sinus passages surrounding the nose) appears to be a primary factor in about one-fifth of toxic shock syndrome cases in children, according to a report in the June issue of Archives of Otolaryngology-Head & Neck Surgery.

Senate committee to markup foreign aid reform bill

The Senate Foreign Relations Committee is set to "mark up the Kerry-Lugar foreign aid reform bill Tuesday," Foreign Policy's blog, "The Cable" reports. It is one of "several foreign-aid reform bills in play, [and] is seen as a strong but relatively modest attempt to increase the power and stature of the U.S. Agency for International Development (USAID).

Dr James N Glenn, MD - Orthopaedic Surgery in Emporia, KS